Ignite Creation Date:
2025-12-24 @ 6:40 PM
Ignite Modification Date:
2026-04-13 @ 6:59 AM
Study NCT ID:
NCT00302757
Status:
COMPLETED
Last Update Posted:
2014-05-29
First Post:
2006-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Radioimmunotherapy With 90Y-ibritumomab Tiuxetan as Part of a Dose Reduced Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation for the Treatment of Non-Hodgkin Lymphoma
Sponsor:
University Hospital Tuebingen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2005-002206-37
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None